{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:30:27Z","timestamp":1788413427460,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00774-025-01589-9","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T13:27:24Z","timestamp":1739885244000},"page":"57-60","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of evidence for the off-label application of osteoanabolic drugs in fracture healing and spinal fusion"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7091-4324","authenticated-orcid":false,"given":"Hiroshi","family":"Kawaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"1589_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra067395","volume":"357","author":"E Canalis","year":"2007","unstructured":"Canalis E, Giustina A, Bilezikian JP (2007) Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357:905\u2013916","journal-title":"N Engl J Med"},{"key":"1589_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02469-1","author":"VN M\u00e4kinen","year":"2024","unstructured":"M\u00e4kinen VN, S\u00f8lling AS, McClung M, Langdahl BL (2024) Romosozumab for the treatment of osteoporosis - a systematic review. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-024-02469-1","journal-title":"J Endocrinol Invest"},{"key":"1589_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1359\/jbmr.090731","volume":"25","author":"P Aspenberg","year":"2010","unstructured":"Aspenberg P, Genant HK, Johansson T, Kanis JA, Blumenthal HT (2010) Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 25:404\u2013414. https:\/\/doi.org\/10.1359\/jbmr.090731","journal-title":"J Bone Miner Res"},{"key":"1589_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/17453674.2015.1073050","volume":"87","author":"T Johansson","year":"2016","unstructured":"Johansson T (2016) PTH 1\u201334 (teriparatide) may not improve healing in proximal humerus fractures: a randomized, controlled study of 40 patients. Acta Orthop 87:79\u201382. https:\/\/doi.org\/10.3109\/17453674.2015.1073050","journal-title":"Acta Orthop"},{"key":"1589_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00198-021-06065-4","volume":"33","author":"JW Nieves","year":"2022","unstructured":"Nieves JW, Cosman F, McMahon DJ, Nieves RJ, Rubin J (2022) Teriparatide and pelvic fracture healing: a phase 2 randomized controlled trial. Osteoporos Int 33:239\u2013250. https:\/\/doi.org\/10.1007\/s00198-021-06065-4","journal-title":"Osteoporos Int"},{"key":"1589_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168691","volume":"11","author":"Z Shi","year":"2016","unstructured":"Shi Z, Zhou H, Pan B, Xu Y, Zhang H (2016) Effectiveness of teriparatide on fracture healing: a systematic review and meta-analysis. PLoS ONE 11:e0168691. https:\/\/doi.org\/10.1371\/journal.pone.0168691","journal-title":"PLoS ONE"},{"key":"1589_CR7","doi-asserted-by":"publisher","first-page":"5914502","DOI":"10.1155\/2020\/5914502","volume":"2020","author":"S Han","year":"2020","unstructured":"Han S, Wen SM, Zhao QP, Yu Y, Hu X (2020) The efficacy of teriparatide in improving fracture healing in hip fractures: a systematic review and meta-analysis. Biomed Res Int 2020:5914502. https:\/\/doi.org\/10.1155\/2020\/5914502","journal-title":"Biomed Res Int"},{"key":"1589_CR8","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00198-021-05847-0","volume":"32","author":"K Eastman","year":"2021","unstructured":"Eastman K, Gerlach M, Piec I, Jones T, Hartley E (2021) Effectiveness of parathyroid hormone (PTH) analogues on fracture healing: a meta-analysis. Osteoporos Int 32:1531\u20131546. https:\/\/doi.org\/10.1007\/s00198-021-05847-0","journal-title":"Osteoporos Int"},{"key":"1589_CR9","first-page":"741","volume":"74","author":"L Luo","year":"2024","unstructured":"Luo L, Lin J, Ma W, Zeng F, Cheng J (2024) Effectiveness of teriparatide in improving healing rates and bone-turnover markers of osteoporotic hip fracture: a meta-analysis. J Pak Med Assoc 74:741\u2013751","journal-title":"J Pak Med Assoc"},{"key":"1589_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00774-014-0617-3","volume":"33","author":"N Miyakoshi","year":"2015","unstructured":"Miyakoshi N, Aizawa T, Sasaki S, Kobayashi H, Takaoka K (2015) Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide. J Bone Miner Metab 33:553\u2013559. https:\/\/doi.org\/10.1007\/s00774-014-0617-3","journal-title":"J Bone Miner Metab"},{"key":"1589_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12891-017-1878-5","volume":"18","author":"WL Yeh","year":"2017","unstructured":"Yeh WL, Su CY, Chang CW, Lin YT, Chen CC (2017) Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment. BMC Musculoskelet Disord 18:527. https:\/\/doi.org\/10.1186\/s12891-017-1878-5","journal-title":"BMC Musculoskelet Disord"},{"key":"1589_CR12","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.bone.2012.10.006","volume":"52","author":"CY Chiang","year":"2013","unstructured":"Chiang CY, Zebaze RMD, Ghasem-Zadeh A, McMahon DJ, Rubin J (2013) Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy. Bone 52:360\u2013365. https:\/\/doi.org\/10.1016\/j.bone.2012.10.006","journal-title":"Bone"},{"key":"1589_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00198-017-4286-7","volume":"29","author":"SL Greenspan","year":"2018","unstructured":"Greenspan SL, Vujevich K, Britton C, Rubin J, Nieves RJ (2018) Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur. Osteoporos Int 29:501\u2013506. https:\/\/doi.org\/10.1007\/s00198-017-4286-7","journal-title":"Osteoporos Int"},{"key":"1589_CR14","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/jbmr.3081","volume":"32","author":"NB Watts","year":"2017","unstructured":"Watts NB, Aggers D, McCarthy EF, Nieves RJ, Rubin J (2017) Responses to treatment with teriparatide in patients with atypical femur fractures previously treated with bisphosphonates. J Bone Miner Res 32:1027\u20131033. https:\/\/doi.org\/10.1002\/jbmr.3081","journal-title":"J Bone Miner Res"},{"key":"1589_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jbmr.4461","volume":"37","author":"MJ B\u00e9gin","year":"2022","unstructured":"B\u00e9gin MJ, Audet MC, Chevalley T, Portela M, Padlina I, Hannouche D, Ing Lorenzini K, Meier R, Peter R, Uebelhart B (2022) Fracture risk following an atypical femoral fracture. J Bone Miner Res 37:87\u201394. https:\/\/doi.org\/10.1002\/jbmr.4461","journal-title":"J Bone Miner Res"},{"key":"1589_CR16","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1210\/clinem\/dgz295","volume":"105","author":"DM van de Laarschot","year":"2020","unstructured":"van de Laarschot DM, McKenna MJ, Abrahamsen B, Kearns S, Singer A, Khosla S, Od\u00e9n A, Akesson K, Papapoulos S, Reid IR, Drake MT (2020) Medical management of patients after atypical femur fractures: a systematic review and recommendations from the European Calcified Tissue Society. J Clin Endocrinol Metab 105:1682\u20131699. https:\/\/doi.org\/10.1210\/clinem\/dgz295","journal-title":"J Clin Endocrinol Metab"},{"key":"1589_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2106\/JBJS.19.00790","volume":"102","author":"EH Schemitsch","year":"2020","unstructured":"Schemitsch EH, Miclau T, Karachalios T, Bhandari M, Zura RD (2020) A randomized, placebo-controlled study of romosozumab for the treatment of hip fractures. J Bone Joint Surg Am 102:693\u2013702. https:\/\/doi.org\/10.2106\/JBJS.19.00790","journal-title":"J Bone Joint Surg Am"},{"key":"1589_CR18","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.2106\/JBJS.19.01008","volume":"102","author":"M Bhandari","year":"2020","unstructured":"Bhandari M, Schemitsch EH, Karachalios T, Miclau T, Choueka J (2020) Romosozumab in skeletally mature adults with a fresh unilateral tibial diaphyseal fracture: a randomized phase-2 study. J Bone Joint Surg Am 102:1416\u20131426. https:\/\/doi.org\/10.2106\/JBJS.19.01008","journal-title":"J Bone Joint Surg Am"},{"key":"1589_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/BRS.0000000000004268","volume":"47","author":"ZM Sardar","year":"2022","unstructured":"Sardar ZM, Coury JR, Cerpa M, Bains M, Virk SS, Vaishnav AS, Passias PG, Klineberg EO, Bess S, Shaffrey CI, Smith JS (2022) Best practice guidelines for assessment and management of osteoporosis in adult patients undergoing elective spinal reconstruction. Spine 47:128\u2013135","journal-title":"Spine"},{"key":"1589_CR20","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375:1532\u20131543. https:\/\/doi.org\/10.1056\/NEJMoa1607948","journal-title":"N Engl J Med"},{"key":"1589_CR21","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan CS, Meisner P, Grauer A (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377:1417\u20131427. https:\/\/doi.org\/10.1056\/NEJMoa1708322","journal-title":"N Engl J Med"},{"key":"1589_CR22","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/jbmr.3735","volume":"34","author":"P Chavassieux","year":"2019","unstructured":"Chavassieux P, Chapurlat R, Portero-Muzy N, Roux JP, Garcia P, Brown JP, Libanati C, Cheung AM, Gielen E, Hanley DA, Kendler DL, Zanchetta JR, McClung M, Grauer A, Reginster JY (2019) Bone-forming and antiresorptive effects of romosozumab in postmenopausal women with osteoporosis: bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment. J Bone Miner Res 34:1597\u20131608. https:\/\/doi.org\/10.1002\/jbmr.3735","journal-title":"J Bone Miner Res"},{"key":"1589_CR23","unstructured":"Amgen-Astellas Pharma. Results of the post-marketing survey of Evenity [Internet]. Tokyo, Japan; 2020 [cited 2025 Jan 3]. https:\/\/www.amgen.co.jp\/-\/media\/Themes\/CorporateAffairs\/amgen-co-jp\/amgen-co-jp\/pdf\/3,-d-,0\/3,-d-,3\/Evenity\/evenity_93001a01.pdf. Japanese"},{"key":"1589_CR24","doi-asserted-by":"publisher","first-page":"E1464","DOI":"10.1097\/BRS.0b013e31826ca2a8","volume":"37","author":"S Ohtori","year":"2012","unstructured":"Ohtori S, Inoue G, Orita S, Takahashi K, Eguchi Y, Kamoda H, Arai G, Suzuki M, Ishikawa T, Miyagi M, Toyone T (2012) Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study. Spine 37:E1464\u2013E1468","journal-title":"Spine"},{"key":"1589_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3171\/2014.5.SPINE13656","volume":"21","author":"G Inoue","year":"2014","unstructured":"Inoue G, Ueno M, Nakazawa T, Imura T, Uchida K, Iwase D, Tsujimoto T, Takaso M (2014) Teriparatide increases the insertional torque of pedicle screws during fusion surgery in patients with postmenopausal osteoporosis. J Neurosurg Spine 21:425\u2013431. https:\/\/doi.org\/10.3171\/2014.5.SPINE13656","journal-title":"J Neurosurg Spine"},{"key":"1589_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.4184\/asj.2015.9.4.573","volume":"9","author":"S Ohtori","year":"2015","unstructured":"Ohtori S, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kishida S, Kuniyoshi K, Nakamura J, Kinoshita H, Norimoto M, Inoue T (2015) More than 6 months of teriparatide treatment was more effective for bone union than shorter treatment following lumbar posterolateral fusion surgery. Asian Spine J 9:573\u2013580. https:\/\/doi.org\/10.4184\/asj.2015.9.4.573","journal-title":"Asian Spine J"},{"key":"1589_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005996","volume":"96","author":"A Kaliya-Perumal","year":"2017","unstructured":"Kaliya-Perumal A, Lu ML, Luo CA, Chang MY, Chang CW, Lin CL, Yen YJ (2017) Retrospective radiological outcome analysis following teriparatide use in elderly patients undergoing multilevel instrumented lumbar fusion surgery. Medicine (Baltimore) 96:e5996. https:\/\/doi.org\/10.1097\/MD.0000000000005996","journal-title":"Medicine (Baltimore)"},{"key":"1589_CR28","doi-asserted-by":"publisher","first-page":"E234","DOI":"10.1097\/BSD.0000000000001434","volume":"36","author":"K Maruo","year":"2023","unstructured":"Maruo K, Arizumi F, Kishima K, Masuda K, Chiba T, Takahashi M, Ueda Y, Ohnishi I (2023) Effects of perioperative teriparatide treatment on the Hounsfield unit values at the upper instrumented vertebra in adult spinal deformity surgery. Clin Spine Surg 36:E234\u2013E238. https:\/\/doi.org\/10.1097\/BSD.0000000000001434","journal-title":"Clin Spine Surg"},{"key":"1589_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2106\/JBJS.23.00272","volume":"106","author":"S Mohanty","year":"2024","unstructured":"Mohanty S, Sardar ZM, Hassan FM, Ho K, Smith JS, Bess S, Shaffrey CI, Ames CP, Schwab F, Passias PG, Mundis GM, Burton DC (2024) Impact of teriparatide on complications and patient-reported outcomes of patients undergoing long spinal fusion according to bone density. J Bone Joint Surg Am 106:206\u2013217. https:\/\/doi.org\/10.2106\/JBJS.23.00272","journal-title":"J Bone Joint Surg Am"},{"key":"1589_CR30","doi-asserted-by":"publisher","first-page":"E487","DOI":"10.1097\/BRS.0b013e31828826dd","volume":"38","author":"S Ohtori","year":"2013","unstructured":"Ohtori S, Inoue G, Orita S, Takaso M, Eguchi Y, Ochiai N, Kishida S, Nakamura J, Kinoshita H, Kuniyoshi K, Norimoto M (2013) Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective. Spine 38:E487\u2013E492","journal-title":"Spine"},{"key":"1589_CR31","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00586-015-4342-y","volume":"26","author":"PG Cho","year":"2017","unstructured":"Cho PG, Ji GY, Shin DA, Kim KN, Yoon DH, Ha Y, Kim SW (2017) An effect comparison of teriparatide and bisphosphonate on posterior lumbar interbody fusion in patients with osteoporosis: a prospective cohort study and preliminary data. Eur Spine J 26:691\u2013697. https:\/\/doi.org\/10.1007\/s00586-015-4342-y","journal-title":"Eur Spine J"},{"key":"1589_CR32","doi-asserted-by":"publisher","first-page":"E1014","DOI":"10.1097\/BRS.0000000000002608","volume":"43","author":"RA Buerba","year":"2018","unstructured":"Buerba RA, Sharma A, Ziino C, Bendo JA, Spivak JM, Goldstein JA, Bhatia NN, Bohlman HH (2018) Bisphosphonate and teriparatide use in thoracolumbar spinal fusion: a systematic review and meta-analysis of comparative studies. Spine 43:E1014\u2013E1023","journal-title":"Spine"},{"key":"1589_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237566","volume":"15","author":"SH Cheng","year":"2020","unstructured":"Cheng SH, Kuo YJ, Chen C, Kang YN (2020) Effects of teriparatide and bisphosphonate on spinal fusion procedure: a systematic review and network meta-analysis. PLoS ONE 15:e0237566. https:\/\/doi.org\/10.1371\/journal.pone.0237566","journal-title":"PLoS ONE"},{"key":"1589_CR34","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/2021.3.FOCUS2175","volume":"50","author":"V Govindarajan","year":"2021","unstructured":"Govindarajan V, Diaz A, Perez-Roman RJ, Sharif SY, Chaudhary SB, Udo IE, Hsu WK, Patel RD, Albert TJ, Smith HE (2021) Osteoporosis treatment in patients undergoing spinal fusion: a systematic review and meta-analysis. Neurosurg Focus 50:E9. https:\/\/doi.org\/10.3171\/2021.3.FOCUS2175","journal-title":"Neurosurg Focus"},{"key":"1589_CR35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11657-020-00738-z","volume":"15","author":"SHL Tsai","year":"2020","unstructured":"Tsai SHL, Chien RS, Lichter K, Chiang CJ, Hsu CC (2020) Teriparatide and bisphosphonate use in osteoporotic spinal fusion patients: a systematic review and meta-analysis. Arch Osteoporos 15:158. https:\/\/doi.org\/10.1007\/s11657-020-00738-z","journal-title":"Arch Osteoporos"},{"key":"1589_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2106\/JBJS.16.00230","volume":"99","author":"S Ebata","year":"2017","unstructured":"Ebata S, Takahashi J, Hasegawa T, Matsuyama Y, Iida T, Nakamura H, Kawakami N, Taneichi H, Yanase M, Haro H, Shimizu K (2017) Role of weekly teriparatide administration in osseous union enhancement within six months after posterior or transforaminal lumbar interbody fusion for osteoporosis-associated lumbar degenerative disorders: a multicenter, prospective randomized study. J Bone Joint Surg Am 99:365\u2013372. https:\/\/doi.org\/10.2106\/JBJS.16.00230","journal-title":"J Bone Joint Surg Am"},{"key":"1589_CR37","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/BRS.0000000000003426","volume":"45","author":"H Oba","year":"2020","unstructured":"Oba H, Takahashi J, Yokomichi H, Ohtori S, Eguchi Y, Tani T, Yamada T, Suzuki M, Takaso M, Nakamura J, Ishikawa T, Kamoda H (2020) Weekly teriparatide versus bisphosphonate for bone union during 6 months after multi-level lumbar interbody fusion for osteoporotic patients: a multicenter, prospective, randomized study. Spine 45:863\u2013871","journal-title":"Spine"},{"key":"1589_CR38","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.otsr.2018.07.015","volume":"104","author":"M Ide","year":"2018","unstructured":"Ide M, Yamada K, Kaneko K, Ishiguro N, Saito T, Hirano T, Takahashi H, Kawai M (2018) Combined teriparatide and denosumab therapy accelerates spinal fusion following posterior lumbar interbody fusion. Orthop Traumatol Surg Res 104:1043\u20131048. https:\/\/doi.org\/10.1016\/j.otsr.2018.07.015","journal-title":"Orthop Traumatol Surg Res"},{"key":"1589_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/17453674.2017.1300745","volume":"88","author":"H Ledin","year":"2017","unstructured":"Ledin H, Good L, Johansson T, Aspenberg P (2017) No effect of teriparatide on migration in total knee replacement. Acta Orthop 88:259\u2013262. https:\/\/doi.org\/10.1080\/17453674.2017.1300745","journal-title":"Acta Orthop"},{"key":"1589_CR40","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1007\/s11999-015-4669-z","volume":"474","author":"M Bhandari","year":"2016","unstructured":"Bhandari M, Jin L, See K, Wu T, Edwards C (2016) Does teriparatide improve femoral neck fracture healing: results from a randomized placebo-controlled trial. Clin Orthop Relat Res 474:1234\u20131244. https:\/\/doi.org\/10.1007\/s11999-015-4669-z","journal-title":"Clin Orthop Relat Res"},{"key":"1589_CR41","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.2106\/JBJS.15.01217","volume":"98","author":"P Aspenberg","year":"2016","unstructured":"Aspenberg P, Malouf J, Tarantino U, Reid IR, Lyles KW, Saag KG, Yuan Z, Nordsletten L, Madsen JE (2016) Effects of teriparatide compared with risedronate on recovery after pertrochanteric hip fracture: results of a randomized, active-controlled, double-blind clinical trial at 26 weeks. J Bone Joint Surg Am 98:1868\u20131878. https:\/\/doi.org\/10.2106\/JBJS.15.01217","journal-title":"J Bone Joint Surg Am"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-025-01589-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-025-01589-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-025-01589-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:24:30Z","timestamp":1744493070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-025-01589-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1589"],"URL":"https:\/\/doi.org\/10.1007\/s00774-025-01589-9","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"5 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author does not have any potential conflicts of interest with respect to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}